Northern Trust Corp Angion Biomedica Corp. Transaction History

Northern Trust Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.94 - $1.23 $15,728 - $20,580	16,732 Added 98.1%	33,788 $31,000
Q2 2022 Aug 12, 2022	SELL	$1.1 - $2.23 $167,784 - $340,144	-152,531 Reduced 89.94%	17,056 $20,000
Q1 2022 May 13, 2022	SELL	$1.72 - $2.96 $13,878 - $23,884	-8,069 Reduced 4.54%	169,587 $360,000
Q4 2021 Feb 08, 2022	SELL	$2.35 - $9.95 $1,555 - $6,586	-662 Reduced 0.37%	177,656 $515,000
Q3 2021 Nov 15, 2021	BUY	$9.31 - $13.25 $1.06 Million - $1.51 Million	113,787 Added 176.33%	178,318 $1.74 Million

Q2 2021 Aug 13, 2021	SELL	$13.02 - $17.83 $2,512 - $3,441	-193 Reduced 0.3%	64,531 $839,000
Q1 2021 May 12, 2021	BUY	$15.01 - $25.74 $971,507 - $1.67 Million	64,724 New	64,724 $1.17 Million

Ticker ANGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,113,300
Description
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.